EcoDrugPlus

Aurora Kinase A

Ensembl ID : ENSPKIG00000003609
Gene Symbol: AURKA
1 Cross references
232 Possible Orthologues:

Aurora Kinase B-Like

Ensembl ID : ENSPKIG00000011146
Gene Symbol: LOC111835424
3 Cross references
204 Possible Orthologues:

Aurora Kinase B-Like

Ensembl ID : ENSPKIG00000019611
Gene Symbol: LOC111852950
3 Cross references
204 Possible Orthologues:

Bcl-2-Like Protein 1

Ensembl ID : ENSPKIG00000024053
Gene Symbol: LOC111835171
3 Cross references
160 Possible Orthologues:

Beta-2 Adrenergic Receptor-Like

Ensembl ID : ENSPKIG00000017550
Gene Symbol: LOC111850095
3 Cross references
193 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSPKIG00000008713
Gene Symbol: BACE1
3 Cross references
218 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSPKIG00000022593
Gene Symbol: BDKRB2
4 Cross references
146 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSPKIG00000020042
Gene Symbol: BDKRB2
3 Cross references
287 Possible Orthologues:

Calcitonin Receptor Like Receptor

Ensembl ID : ENSPKIG00000015536
Gene Symbol: CALCRL
3 Cross references
147 Possible Orthologues:

Calcium Channel, Voltage-Dependent, L Type, Alpha 1c Subunit

Ensembl ID : ENSPKIG00000000555
Gene Symbol: CACNA1C
1 Cross references
213 Possible Orthologues:

Calcium Channel, Voltage-Dependent, L Type, Alpha 1d Subunit, A

Ensembl ID : ENSPKIG00000004666
Gene Symbol: CACNA1DA
1 Cross references
213 Possible Orthologues:

Calcium Channel, Voltage-Dependent, L Type, Alpha 1s Subunit, A

Ensembl ID : ENSPKIG00000004942
Gene Symbol: CACNA1SA
1 Cross references
259 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).